BAM
CLB icon

Brave Asset Management’s Core Laboratories CLB Stock Holding History

Brave Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-100
Closed -$11K – 406
2016
Q1 		$11K Hold
100
– – 0.01% 337
2015
Q4 		$11K Hold
100
– – 0.01% 342
2015
Q3 		$10K Sell
100
-350
-78% -$38.1K 0.01% 336
2015
Q2 		$51K Hold
450
– – 0.04% 229
2015
Q1 		$47K Buy
450
+350
+350% +$37.3K 0.03% 228
2014
Q4 		$12K Buy
+100
New +$13.1K 0.01% 345

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Brave Asset Management's CLB Position: Q2 2016 in Review

Brave Asset Management sold out of Core Laboratories (CLB) in Q2 2016, closing a stake of 100 shares — an estimated $11K sold.

Brave Asset Management first reported a position in CLB in Q4 2014 and held it in 6 quarters. The position peaked at $51K in Q2 2015. 384 funds tracked by Wall St. Rank hold CLB as of Q2 2016.

  • Brave Asset Management reported no remaining Core Laboratories position as of Q2 2016 after selling out during the quarter.
  • Brave Asset Management sold 100 Core Laboratories shares in Q2 2016, an estimated $11K.
  • Brave Asset Management first reported a position in Core Laboratories in Q4 2014 and held it in 6 quarters.
  • Brave Asset Management's Core Laboratories position peaked at $51K in Q2 2015.
  • 384 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2016.

Based on Brave Asset Management's 13F filing for Q2 2016, filed 9 Aug 2016.